Loading...
Shanghai Pioneer Holding Ltd
1345.HK•HKSE
Healthcare
Medical - Pharmaceuticals
HK$2.21
HK$-0.09(-3.91%)
Hong Kong Market opens in 63h 59mShanghai Pioneer Holding Ltd (1345.HK) AI-Powered Stock Analysis
See how Shanghai Pioneer Holding Ltd scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerShanghai Pioneer Holding Ltd (1345.HK) Stock Overall Grade
Shanghai Pioneer Holding Ltd’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Shanghai Pioneer Holding Ltd's overall stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
BScore
68/100Key Ratios
AScore
80/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
C+Score
50/100Shanghai Pioneer Holding Ltd (1345.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (68/100, B) highlight its stability, while Key Ratios (80/100, A) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Shanghai Pioneer Holding Ltd stock grade, including financials, comparisons, and forecasts.